BRIEF published on 08/18/2025 at 18:35, 11 months 15 days ago Sanofi Reports Total Shares and Voting Rights for July 2025 Voting Rights French Commercial Code Shares 2025 Sanofi
PRESS RELEASE published on 08/18/2025 at 18:30, 11 months 15 days ago Sanofi: Information concerning the total number of voting rights and shares - July 2025 Sanofi discloses total voting rights and issued shares as per French commercial and stock market regulations. Details available on their website Voting Rights Shares French Regulations Investor Relations Sanofi
BRIEF published on 08/14/2025 at 07:05, 11 months 20 days ago Sanofi's rilzabrutinib granted orphan drug designation in the EU Sanofi EMA Orphan Drug Rilzabrutinib IgG4 Disease
PRESS RELEASE published on 08/14/2025 at 07:00, 11 months 20 days ago Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease Sanofi’s rilzabrutinib granted orphan designation in EU for IgG4-related disease. Positive Phase 2 results presented at EULAR 2025 Congress showcasing efficacy and safety profile Sanofi Rilzabrutinib Orphan Designation IgG4-related Disease EULAR 2025
PRESS RELEASE published on 08/11/2025 at 18:30, 11 months 22 days ago Sanofi: Disclosure of trading in own shares
BRIEF published on 08/06/2025 at 07:05, 11 months 28 days ago Sanofi Finalizes Acquisition of Vigil Neuroscience Acquisition Sanofi Neurology Vigil Neuroscience VG-3927
PRESS RELEASE published on 08/06/2025 at 07:00, 11 months 28 days ago Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc. Sanofi announces completion of Vigil Neuroscience, Inc. acquisition, reinforcing neurology pipeline with VG-3927 for Alzheimer's. Vigil shareholders receive CVR. VGL101 not acquired Acquisition Sanofi Neurology Alzheimer's Vigil Neuroscience
BRIEF published on 07/22/2025 at 07:35, 1 year ago Sanofi acquires Vicebio to boost its respiratory vaccine portfolio Sanofi Acquisition Vicebio Respiratory Vaccines Molecular Clamp Technology Biotechnology Investment
PRESS RELEASE published on 07/22/2025 at 07:30, 1 year ago Press Release: Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline Sanofi acquires Vicebio, enhancing respiratory vaccines pipeline with 'Molecular Clamp' technology and combination vaccine candidates for RSV and hMPV, expanding capabilities in vaccine development Sanofi Vicebio Respiratory Vaccines Molecular Clamp Technology Combination Vaccines
BRIEF published on 07/18/2025 at 07:05, 1 year ago Sanofi Completes Acquisition of Blueprint Medicines Acquisition Sanofi Blueprint Medicines Systemic Mastocytosis Ayvakit
Published on 08/01/2026 at 01:20, 2 days 14 hours ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 2 days 15 hours ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 2 days 15 hours ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 07/31/2026 at 23:20, 2 days 16 hours ago Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.
Published on 08/03/2026 at 15:40, 37 minutes ago Africa Tech Festival Unveils First Speakers for 2026
Published on 08/03/2026 at 15:20, 56 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 08/03/2026 at 15:19, 57 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 08/03/2026 at 10:58, 5 hours 18 minutes ago GUILLEMOT CORPORATION| Weekly report share buyback from July 27 to July 31 2026
Published on 08/03/2026 at 08:29, 7 hours 48 minutes ago Launch of a €225 million tranche of its share buyback programme
Published on 08/03/2026 at 07:00, 9 hours 17 minutes ago BIOPHYTIS PROVIDES AN UPDATE AND SHARE STRATEGIC DRIVERS SUPPORTING ITS HONG KONG JOINT VENTURE
Published on 07/31/2026 at 21:00, 2 days 19 hours ago Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:27, 2 days 20 hours ago Share retention commitments (Dutreil Agreement)
